vTv Therapeutics Reports Q3 2026: $11.6 Million Net Loss and $36. ...
Cash of $77.2 Million Expected to Fund Operations Through Mid-2027 CATT1 Topline Readout Related Stocks: VTVT ,
Cash of $77.2 Million Expected to Fund Operations Through Mid-2027 CATT1 Topline Readout Related Stocks: VTVT ,